Visser GW[au] - Search Results

Year	Number of Results
1980	1
1981	1
1985	1
1986	1
1988	1
1989	2
1990	1
1991	1
1992	1
1993	5
1994	1
1996	2
1997	1
1998	1
1999	1
2000	2
2001	2
2002	1
2003	4
2004	2
2005	2
2006	1
2007	1
2008	1
2009	2
2010	2
2011	4
2012	1
2013	2
2014	2
2015	2
2016	1
2017	1
2021	0

1

The promise of immuno-PET in radioimmunotherapy.

Verel I, Visser GW, van Dongen GA. Verel I, et al. Among authors: visser gw. J Nucl Med. 2005 Jan;46 Suppl 1:164S-71S. J Nucl Med. 2005. PMID: 15653665 Free article. Review.

2

89Zr-PET radiochemistry in the development and application of therapeutic monoclonal antibodies and other biologicals.

Vugts DJ, Visser GW, van Dongen GA. Vugts DJ, et al. Among authors: visser gw. Curr Top Med Chem. 2013;13(4):446-57. doi: 10.2174/1568026611313040005. Curr Top Med Chem. 2013. PMID: 23432007 Review.

3

Immuno-PET: a navigator in monoclonal antibody development and applications.

van Dongen GA, Visser GW, Lub-de Hooge MN, de Vries EG, Perk LR. van Dongen GA, et al. Among authors: visser gw. Oncologist. 2007 Dec;12(12):1379-89. doi: 10.1634/theoncologist.12-12-1379. Oncologist. 2007. PMID: 18165614 Free article. Review.

4

Photosensitizer-antibody conjugates for detection and therapy of cancer.

van Dongen GA, Visser GW, Vrouenraets MB. van Dongen GA, et al. Among authors: visser gw. Adv Drug Deliv Rev. 2004 Jan 13;56(1):31-52. doi: 10.1016/j.addr.2003.09.003. Adv Drug Deliv Rev. 2004. PMID: 14706444 Review.

5

89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied?

Van Dongen GA, Huisman MC, Boellaard R, Harry Hendrikse N, Windhorst AD, Visser GW, Molthoff CF, Vugts DJ. Van Dongen GA, et al. Among authors: visser gw. Q J Nucl Med Mol Imaging. 2015 Mar;59(1):18-38. Epub 2014 Dec 17. Q J Nucl Med Mol Imaging. 2015. PMID: 25517081 Review.

6

Basic principles, applications in oncology and improved selectivity of photodynamic therapy.

Vrouenraets MB, Visser GW, Snow GB, van Dongen GA. Vrouenraets MB, et al. Among authors: visser gw. Anticancer Res. 2003 Jan-Feb;23(1B):505-22. Anticancer Res. 2003. PMID: 12680139 Review.

7

Synthesis and biodistribution of [18F]-5-fluorocytosine.

Visser GW, Boele S, Knops GH, Herscheid JD, Hoekstra A. Visser GW, et al. Nucl Med Commun. 1985 Aug;6(8):455-9. doi: 10.1097/00006231-198508000-00005. Nucl Med Commun. 1985. PMID: 4069471

8

Development of novel ADCs: conjugation of tubulysin analogues to trastuzumab monitored by dual radiolabeling.

Cohen R, Vugts DJ, Visser GW, Stigter-van Walsum M, Bolijn M, Spiga M, Lazzari P, Shankar S, Sani M, Zanda M, van Dongen GA. Cohen R, et al. Among authors: visser gw. Cancer Res. 2014 Oct 15;74(20):5700-10. doi: 10.1158/0008-5472.CAN-14-1141. Epub 2014 Aug 21. Cancer Res. 2014. PMID: 25145670 Free article.

9

89Zr-nanocolloidal albumin-based PET/CT lymphoscintigraphy for sentinel node detection in head and neck cancer: preclinical results.

Heuveling DA, Visser GW, Baclayon M, Roos WH, Wuite GJ, Hoekstra OS, Leemans CR, de Bree R, van Dongen GA. Heuveling DA, et al. Among authors: visser gw. J Nucl Med. 2011 Oct;52(10):1580-4. doi: 10.2967/jnumed.111.089557. Epub 2011 Sep 2. J Nucl Med. 2011. PMID: 21890880 Free article.

10

Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine.

Vosjan MJ, Perk LR, Visser GW, Budde M, Jurek P, Kiefer GE, van Dongen GA. Vosjan MJ, et al. Among authors: visser gw. Nat Protoc. 2010 Apr;5(4):739-43. doi: 10.1038/nprot.2010.13. Epub 2010 Mar 25. Nat Protoc. 2010. PMID: 20360768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results